BSP:N1BI34 (USA)  
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc

R$ 28.71 (0%) Oct 3
On watch
P/E:
970.18
P/B:
7.17
Market Cap:
R$ 54.92B ($ 10.63B)
Enterprise V:
R$ 53.24B ($ 10.30B)
Volume:
2.00
Avg Vol (2M):
482.00
Also Trade In:
Volume:
2.00
Market Cap R$:
54.92B
Market Cap $:
10.63B
PE Ratio:
970.18
Avg Vol (2-Month):
482.00
Enterprise Value R$:
53.24B
Enterprise Value $:
10.30B
PB Ratio:
7.17
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt 2.41
Equity-to-Asset 0.71
Debt-to-Equity 0.19
Debt-to-EBITDA 5.87
Interest Coverage 9.23
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.26
Distress
Grey
Safe
Beneish M-Score -1.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 77.03
9-Day RSI 67.38
14-Day RSI 63.23
6-1 Month Momentum % 20.64
12-1 Month Momentum % 5.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.57
Quick Ratio 3.47
Cash Ratio 2.27
Days Inventory 588.12
Days Sales Outstanding 59.12
Days Payable 1062.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.5

Financials (Next Earnings Date:2022-11-01 Est.)

BSP:N1BI34's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 6,781.623
EPS (TTM) (R$) 0.028
Beta 0
Volatility % 37.51
14-Day RSI 63.23
14-Day ATR (R$) 0.437528
20-Day SMA (R$) 27.4305
12-1 Month Momentum % 5.5
52-Week Range (R$) 19.58 - 29.9
Shares Outstanding (Mil) 1,912.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neurocrine Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Neurocrine Biosciences Inc Analysis

Share your research